Evidence map›Paper›PMID 40241824›Full record

ArticleFrontiers in plant science2025

Exploring the Metabolic and Transcriptomic Profiles of

Lingxia Peng, Hongju Li, Lijun Yang, Zongsuo Liang, Xiaodan Zhang

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hypolipidemic Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lingxia PengKey Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Hongju LiKey Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Lijun YangKey Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Zongsuo LiangKey Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Xiaodan ZhangKey Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: This study employed a combination of metabolomics and transcriptomics to analyze the metabolic profiles of Results: A total of 65 metabolites were identified in the tuberous roots, 203 in the fibrous roots, and 235 in the leaves. The main compounds identified included flavonoids, alkaloids, terpenoids, glycosides, ketones, and amino acids and their derivatives. Flavonoids, glycosides, alkaloids, and terpenoids were strongly accumulated in the tuberous roots, while flavonoid alcohols, glycosides, alkaloids, and terpenoids were predominant in the leaves and fibrous roots. The phenylpropanoid biosynthesis pathway and isoflavonoid biosynthesis were found to play a major role in the pharmacological effects of Discussion: These results elucidate the molecular mechanisms behind the differential accumulation of metabolites in different parts of

Indexed as

accumulationdifferent partsmedicinal plantRNA-SeqTetrastigma hemsleyanumUPLC-Q-TOF-MSE

Identifiers

PMID40241824
PMCPMC12000079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.